Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin. 1990

E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
Institute of Immunology, Vienna, Austria.

We present here the molecular characterization of a new activation-induced surface structure on human T lymphocytes, termed LA45, with high homology (93% at protein level) to MHC class I molecules. Antigen modulation and sequential immunoprecipitation experiments revealed that LA45 and HLA class I proteins do not crossreact with the corresponding antibodies. Furthermore, LA45 is not associated with beta 2-m. On the other hand, we could show that the separation of HLA-A,B,C and beta 2m molecules, induced by SDS-denaturation, leads to a conformational change in the heavy chain in such a way that it becomes reactive with LA45. The 90/45 kD LA45 proteins thus appear to be non-beta 2m-associated MHC class I alpha chains that are selectively expressed by activated but not by resting human T lymphocytes.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011948 Receptors, Antigen, T-Cell Molecules on the surface of T-lymphocytes that recognize and combine with antigens. The receptors are non-covalently associated with a complex of several polypeptides collectively called CD3 antigens (CD3 COMPLEX). Recognition of foreign antigen and the major histocompatibility complex is accomplished by a single heterodimeric antigen-receptor structure, composed of either alpha-beta (RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA) or gamma-delta (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA) chains. Antigen Receptors, T-Cell,T-Cell Receptors,Receptors, T-Cell Antigen,T-Cell Antigen Receptor,T-Cell Receptor,Antigen Receptor, T-Cell,Antigen Receptors, T Cell,Receptor, T-Cell,Receptor, T-Cell Antigen,Receptors, T Cell Antigen,Receptors, T-Cell,T Cell Antigen Receptor,T Cell Receptor,T Cell Receptors,T-Cell Antigen Receptors
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000945 Antigens, Differentiation, T-Lymphocyte Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function. Antigens, Differentiation, T-Cell,Differentiation Antigens, T-Cell,L3T4 Antigens,Leu Antigens, T-Lymphocyte,T-Cell Differentiation Antigens,T-Lymphocyte Differentiation Antigens,T6 Antigens,Antigens, Differentiation, T Lymphocyte,Differentiation Antigens, T Lymphocyte,Antigens, L3T4,Antigens, T-Cell Differentiation,Antigens, T-Lymphocyte Differentiation,Antigens, T-Lymphocyte Leu,Antigens, T6,Differentiation Antigens, T Cell,Differentiation Antigens, T-Lymphocyte,Leu Antigens, T Lymphocyte,T Cell Differentiation Antigens,T Lymphocyte Differentiation Antigens,T-Lymphocyte Leu Antigens
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
July 1993, Journal of immunology (Baltimore, Md. : 1950),
E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
January 1985, Immunogenetics,
E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
November 1991, The Journal of general virology,
E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
December 1996, Scandinavian journal of immunology,
E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
January 2005, Journal of immunology (Baltimore, Md. : 1950),
E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
January 1984, Experimental and clinical immunogenetics,
E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
May 1996, Immunology,
E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
July 2002, International immunology,
E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
September 2000, Journal of immunology (Baltimore, Md. : 1950),
E Schnabl, and H Stockinger, and O Majdic, and H Gaugitsch, and I J Lindley, and D Maurer, and A Hajek-Rosenmayr, and W Knapp
November 1982, Molecular immunology,
Copied contents to your clipboard!